Drug:
Reaction: PRODUCT DOSE OMISSION ISSUE
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25137532 |
CA |
||
Blood pressure increased, Pneumonia, Poor venous access, Blood potassium decreased, Vertigo, Eczema, Ear discomfort, Irritability, Brain fog, Condition aggravated, Muscle spasms, Fatigue, Vision blurred, Off label use, Product dose omission issue, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, AVACOPAN, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 102 | 25137695 |
US |
2 | |
Asthma, Back injury, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 103 | 25137703 |
US |
2 | |
Dizziness, Fatigue, Alopecia, Headache, Nausea, Vomiting, Abdominal pain upper, Product dose omission issue, |
||||
ELAFIBRANOR, CHOLESTYRAMINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, PREDNISONE, |
||||
| 104 | 25137876 |
US |
24 | 1 |
Product dose omission issue, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 105 | 25137883 |
US |
2 | |
Exposure via skin contact, Product dose omission issue, Wrong technique in device usage process, Accidental exposure to product, |
||||
BELIMUMAB, |
||||
| 106 | 25137890 |
US |
||
Visual impairment, Exposure to extreme temperature, Drug effect less than expected, Wrong technique in device usage process, Product dose omission issue, Product use issue, |
||||
| 107 | 25137917 |
US |
2 | |
Product dose omission issue, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 108 | 25137921 |
US |
36 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 109 | 25137923 |
US |
51 | |
Product dose omission issue, Injection site haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 110 | 25137952 |
US |
69 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 111 | 25137986 |
US |
48 | 2 |
Product dose omission issue, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 112 | 25137993 |
US |
37 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 113 | 25137998 |
US |
75 | |
Product dose omission issue, Product dose omission in error, Device issue, |
||||
TEZEPELUMAB-EKKO, |
||||
| 114 | 25138007 |
US |
2 | |
Malaise, Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 115 | 25132046 |
GB |
51 | 2 |
Lower respiratory tract infection, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 116 | 25132057 |
US |
36 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 117 | 25132091 |
US |
||
Product dose omission issue, Condition aggravated, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 118 | 25132097 |
US |
40 | 2 |
Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 119 | 25132110 |
46 | 2 | |
Gastrooesophageal reflux disease, Drug intolerance, Hypersensitivity, Product use issue, Product dose omission issue, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, |
||||
| 120 | 25132112 |
US |
23 | 1 |
Product storage error, Off label use, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 121 | 25132189 |
US |
19 | 1 |
Nasal congestion, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 122 | 25132190 |
US |
2 | |
Head injury, Product administration error, Product dose omission issue, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 123 | 25132203 |
US |
1 | |
Rhinorrhoea, Asthma, Product dose omission issue, Rebound effect, Rash, |
||||
DUPILUMAB, EPINEPHRINE, ALBUTEROL SULFATE, QUETIAPINE, BUSPIRONE HYDROCHLORIDE, |
||||
| 124 | 25132243 |
US |
39 | 1 |
Product dose omission issue, Device defective, Product label issue, Off label use, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 125 | 25132300 |
US |
2 | |
Sleep disorder, Product dose omission issue, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, INSULIN GLARGINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, MONTELUKAST, |
||||
| 126 | 25132320 |
US |
||
Product storage error, Device delivery system issue, Incorrect dose administered by device, Product dose omission issue, Visual impairment, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 127 | 25132345 |
US |
1 | |
Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 128 | 25132350 |
US |
2 | |
Product dose omission issue, Product label issue, |
||||
RIVAROXABAN, |
||||
| 129 | 25132355 |
US |
76 | 2 |
Injection site pain, Off label use, Kaleidoscope vision, Vitreous floaters, Product dose omission issue, |
||||
FARICIMAB, |
||||
| 130 | 25132432 |
US |
69 | |
Accidental exposure to product, Product dose omission issue, Blood disorder, |
||||
TEZEPELUMAB-EKKO, |
||||
| 131 | 25132458 |
AU |
42 | 2 |
Uveitis, Bradyphrenia, Fatigue, Dizziness, Facial pain, Inappropriate schedule of product administration, Product dose omission issue, |
||||
SEMAGLUTIDE, |
||||
| 132 | 25132509 |
US |
1 | |
No adverse event, Inappropriate schedule of product administration, Product availability issue, Product dose omission issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 133 | 25132534 |
US |
2 | |
Product reconstitution quality issue, Product dose omission issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, CALCIUM, GABAPENTIN, APIXABAN, IRON, ASPIRIN, MIRTAZAPINE, |
||||
| 134 | 25132542 |
US |
82 | 2 |
Product dose omission issue, Wrong technique in product usage process, Product use issue, |
||||
VELPATASVIR AND SOFOSBUVIR, VELPATASVIR AND SOFOSBUVIR, |
||||
| 135 | 25132545 |
US |
37 | 1 |
Product dose omission issue, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, LORATADINE, LORATADINE ORAL, AMLODIPINE BESYLATE, |
||||
| 136 | 25132554 |
US |
67 | 2 |
Tremor, Product dose omission issue, |
||||
DEUTETRABENAZINE, |
||||
| 137 | 25132594 |
US |
2 | |
Product dose omission issue, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 138 | 25132657 |
US |
68 | |
Product dose omission issue, Device delivery system issue, No adverse event, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, |
||||
| 139 | 25132691 |
US |
1 | |
Product dose omission issue, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 140 | 25132729 |
CA |
75 | 2 |
Arterial stenosis, Blood uric acid increased, Dyspepsia, Dysphagia, Dyspnoea exertional, Heart valve incompetence, Osteoarthritis, Pain in extremity, Product dose omission issue, Product supply issue, Dyspnoea, Fatigue, Chest pain, Myalgia, |
||||
MAVACAMTEN, MAVACAMTEN, OIL, BIOTIN, HAIR, EZETIMIBE, FOLIC ACID, MAGNESIUM, MELATONIN, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, TELMISARTAN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 141 | 25132812 |
US |
||
Product dose omission issue, |
||||
AMBRISENTAN, |
||||
| 142 | 25132835 |
US |
42 | 2 |
Device defective, Needle issue, Accidental exposure to product, Product dose omission issue, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 143 | 25132913 |
US |
42 | |
Product dose omission issue, |
||||
BELATACEPT, |
||||
| 144 | 25132940 |
BE |
||
Product dose omission issue, Device issue, |
||||
GOLIMUMAB, |
||||
| 145 | 25132965 |
US |
49 | 1 |
Hypervolaemia, Product dose omission issue, |
||||
MACITENTAN, TADALAFIL, |
||||
| 146 | 25133206 |
US |
2 | |
Accidental exposure to product, Product dose omission issue, Device malfunction, Device leakage, |
||||
SECUKINUMAB, GABAPENTIN, DULOXETINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, MIRTAZAPINE, |
||||
| 147 | 25133346 |
US |
72 | 1 |
Product dose omission issue, |
||||
RIVAROXABAN, |
||||
| 148 | 25133377 |
US |
63 | 1 |
Skin cancer, Product dose omission issue, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 149 | 25133436 |
US |
||
Back disorder, Product dose omission issue, Off label use, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 150 | 25133470 |
US |
36 | 2 |
Product dose omission issue, Accidental exposure to product, Device issue, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 151 | 25133576 |
US |
56 | 1 |
Product dose omission issue, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 152 | 25133659 |
40 | 2 | |
Psychotic disorder, Hunger, Feeling abnormal, Fatigue, Agoraphobia, Thinking abnormal, Somnolence, Dyspnoea, Anxiety, Panic attack, Product dose omission issue, Insurance issue, Therapy interrupted, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
| 153 | 25133661 |
73 | 1 | |
Nasopharyngitis, Feeling abnormal, Product use issue, Product dose omission issue, Therapy interrupted, Overdose, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUOXETINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCHLOROTHIAZIDE, |
||||
| 154 | 25133697 |
US |
||
Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 155 | 25133699 |
US |
71 | 2 |
Influenza, Product dose omission issue, Off label use, |
||||
PACRITINIB, |
||||
| 156 | 25133711 |
US |
||
Gastroenteritis viral, Nausea, Vomiting, Product dose omission issue, |
||||
BETAINE, PYRIDOXINE HYDROCHLORIDE, ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS, ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM, ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS, AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS, BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS, ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS, ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE, ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS, ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, ERGOCALCIFEROL, |
||||
| 157 | 25133802 |
US |
||
Cough, Nasopharyngitis, Product dose omission issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 158 | 25133845 |
US |
||
Product dose omission issue, Drug delivery system malfunction, No adverse event, |
||||
OMALIZUMAB, |
||||
| 159 | 25133861 |
US |
64 | 2 |
Product dose omission issue, Accidental underdose, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 160 | 25133863 |
US |
52 | 1 |
Product dose omission issue, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 161 | 25133864 |
US |
69 | |
Product dose omission issue, Constipation, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 162 | 25133927 |
US |
7 | 1 |
Rebound atopic dermatitis, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 163 | 25133936 |
US |
59 | 1 |
Rash pruritic, Product dose omission issue, Pruritus, |
||||
DUPILUMAB, |
||||
| 164 | 25134073 |
US |
||
Wrong technique in product usage process, Eyeglasses therapy, Device delivery system issue, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 165 | 25134166 |
US |
61 | 1 |
Product dose omission issue, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 166 | 25134179 |
US |
1 | |
Product dose omission issue, |
||||
TREPROSTINIL, |
||||
| 167 | 25134212 |
US |
61 | 1 |
Photopsia, Product dose omission issue, |
||||
AVAPRITINIB, |
||||
| 168 | 25134386 |
US |
||
Wrong technique in device usage process, Product dose omission issue, |
||||
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 169 | 25134394 |
US |
40 | 1 |
Product dose omission issue, |
||||
DOLUTEGRAVIR SODIUM AND LAMIVUDINE, FENOFIBRATE, |
||||
| 170 | 25134413 |
US |
44 | 2 |
Hereditary angioedema, Hereditary angioedema, Abdominal pain, Product dose omission issue, |
||||
| 171 | 25134418 |
US |
48 | 1 |
Product dose omission issue, |
||||
ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE, |
||||
| 172 | 25134487 |
US |
64 | 1 |
Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 173 | 25134514 |
US |
1 | |
Gastrostomy, Aspiration, Pneumonia, Infection, Product dose omission issue, |
||||
VAMOROLONE, LEVETIRACETAM, LACOSAMIDE, ERGOCALCIFEROL, HYDROXYZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALBUTEROL SULFATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, GOLODIRSEN, |
||||
| 174 | 25134529 |
US |
76 | 2 |
Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 175 | 25134573 |
US |
61 | 2 |
Product dose omission issue, Colitis ulcerative, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 176 | 25134625 |
US |
81 | |
Pneumonia, Influenza, Cardiac failure, Fall, Head injury, Product dose omission issue, |
||||
ACALABRUTINIB, |
||||
| 177 | 25134642 |
US |
||
Obstructive airways disorder, Dyspnoea, Product dose omission issue, Product colour issue, |
||||
LITHIUM CARBONATE, |
||||
| 178 | 25134687 |
US |
2 | |
Product dose omission issue, |
||||
BELIMUMAB, |
||||
| 179 | 25134688 |
US |
69 | 2 |
Gait disturbance, Corneal cyst, Eye infection, Eye pain, Product dose omission issue, Blood glucose decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 180 | 25134690 |
CA |
1 | |
Hepatic cirrhosis, Joint swelling, Arthralgia, Condition aggravated, Somnolence, General physical health deterioration, Weight increased, Pain, Weight decreased, Product dose omission issue, |
||||
ETANERCEPT, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 181 | 25134724 |
US |
65 | 1 |
Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 182 | 25134742 |
US |
||
Intentional dose omission, Product dose omission issue, Device use issue, Wrong technique in device usage process, Throat irritation, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 183 | 25134859 |
US |
78 | 2 |
Injection site haemorrhage, Fall, Off label use, Accidental exposure to product, Vitamin D decreased, Product dose omission issue, Device issue, |
||||
OMALIZUMAB, ROSUVASTATIN, LEVOTHYROXINE, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYZINE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CLONAZEPAM, |
||||
| 184 | 25134929 |
US |
1 | |
Pneumonia, Nausea, Flushing, Dyspnoea, Oedema peripheral, Chest pain, Respiratory tract infection, Sputum discoloured, Headache, Constipation, Vomiting, Gastrooesophageal reflux disease, Weight decreased, Decreased appetite, Fatigue, Blood glucose abnormal, Diarrhoea, Memory impairment, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TIRZEPATIDE, NINTEDANIB, NINTEDANIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, APIXABAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PRIMIDONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUMETANIDE, INSULIN GLARGINE, OXYGEN, 0XYGEN, GABAPENTIN, EVOLOCUMAB, DRONEDARONE, |
||||
| 185 | 25135047 |
US |
38 | 2 |
Dyspepsia, Influenza, Product dose omission issue, |
||||
TOFACITINIB, |
||||
| 186 | 25135107 |
US |
32 | 2 |
Dehydration, Cardiac disorder, Abdominal pain upper, Oropharyngeal pain, Dizziness, Eye disorder, Erythema, Dry skin, Bradyphrenia, Oscillopsia, Hepatic enzyme increased, White blood cell count decreased, Neutrophil count decreased, Papule, Fatigue, Cough, Rash, Nausea, Diarrhoea, Product dose omission issue, |
||||
NIROGACESTAT, |
||||
| 187 | 25135115 |
US |
20 | 2 |
Nephrotic syndrome, Urinary tract infection, Weight decreased, Exposure during pregnancy, Weight increased, Product dose omission issue, Product use issue, Hereditary angioedema, |
||||
WATER, STERILE WATER, STERILE WATER FOR INJECTION, EPINEPHRINE, ADRENALINUM, C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 188 | 25135168 |
US |
82 | 2 |
Fall, Injury, Product dose omission issue, Product use complaint, Product container issue, |
||||
LATANOPROST, |
||||
| 189 | 25135174 |
US |
64 | 1 |
Neuropathy peripheral, Neuropathy peripheral, Pancreatic atrophy, Mental impairment, Device related infection, Catheter site infection, Abdominal discomfort, Weight decreased, Paraesthesia, Oral pain, Oropharyngeal pain, Chills, Tremor, Asthenia, Taste disorder, Paraesthesia oral, Brain fog, Tendonitis, Taste disorder, Abnormal faeces, Fatigue, Product dose omission issue, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, OXALIPLATIN, |
||||
| 190 | 25135335 |
35 | ||
Product dose omission issue, Fatigue, |
||||
RUXOLITINIB, |
||||
| 191 | 25135355 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 192 | 25135358 |
US |
74 | 2 |
Product dose omission issue, |
||||
POMALIDOMIDE, |
||||
| 193 | 25135405 |
US |
1 | |
Rebound eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 194 | 25135461 |
US |
||
Product dose omission issue, |
||||
ISOTRETINOIN, |
||||
| 195 | 25135493 |
US |
34 | 2 |
Hospitalisation, Device defective, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 196 | 25135511 |
US |
2 | |
Product dose omission issue, |
||||
FLUTICASONE PROPIONATE, |
||||
| 197 | 25135550 |
IN |
||
Diabetic ketoacidosis, Product dose omission issue, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN HUMAN, MEROPENEM, TIGECYCLINE, LINEZOLID, AZTREONAM, POLYMYXIN B SULFATE, POLYMYXIN B, ANIDULAFUNGIN, AMPHOTERICIN B, |
||||
| 198 | 25135591 |
US |
83 | |
Eye disorder, Muscular weakness, Wrong technique in product usage process, Incorrect dose administered, Product dose omission issue, Device issue, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 199 | 25135597 |
CN |
32 | 1 |
Device deployment issue, Injection site pain, Injection site haemorrhage, Accidental exposure to product, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 200 | 25135625 |
US |
2 | |
Product dose omission issue, Central nervous system lesion, Magnetic resonance imaging abnormal, |
||||
DIROXIMEL FUMARATE, BACLOFEN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TIZANIDINE HYDROCHLORIDE, ERGOCALCIFEROL, VITAMIN C, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FESOTERODINE FUMARATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MAGNESIUM, LISINOPRIL, OXYBUTYNIN CHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28